Production (Stage)
Centessa Pharmaceuticals plc
CNTA
$12.60
$0.221.78%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.60% | 87.95% | 84.28% | -2.88% | -33.52% |
| Total Receivables | 41.77% | 15.70% | 31.76% | 65.33% | 58.91% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -47.63% | -49.12% | -51.30% | -96.71% | -40.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -38.24% | -54.37% | -52.52% | -18.44% | 21.47% |
| Total Current Assets | 22.23% | 70.24% | 70.96% | 1.45% | -25.98% |
|
|
|||||
| Total Current Assets | 22.23% | 70.24% | 70.96% | 1.45% | -25.98% |
| Net Property, Plant & Equipment | -9.39% | -9.23% | -8.82% | -8.25% | -6.26% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.94% | -11.08% | -7.55% | 6.71% | 414.06% |
| Total Assets | 60.84% | 60.11% | 61.57% | 1.51% | -18.74% |
|
|
|||||
| Total Accounts Payable | -31.56% | -39.54% | -31.39% | -52.01% | -47.81% |
| Total Accrued Expenses | -10.77% | 85.24% | -23.41% | -7.22% | 53.90% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.13% | -- | 19.71% | 20.00% | 32.66% |
| Total Finance Division Other Current Liabilities | 201.89% | -0.84% | 159.75% | 27.02% | -80.09% |
| Total Other Current Liabilities | 201.89% | -0.84% | 159.75% | 27.02% | -80.09% |
| Total Current Liabilities | -11.78% | 47.26% | -24.45% | -21.00% | -7.58% |
|
|
|||||
| Total Current Liabilities | -11.78% | 47.26% | -24.45% | -21.00% | -7.58% |
| Long-Term Debt | 42.26% | 43.91% | 2.30% | 4.37% | 7.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.19% | -6.77% | -6.40% | -6.03% | -6.11% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | -- | -- | -- |
| Total Liabilities | 25.30% | 41.33% | -6.27% | -3.81% | 2.18% |
|
|
|||||
| Common Stock & APIC | 39.27% | 40.33% | 41.01% | 17.53% | 6.14% |
| Retained Earnings | -28.30% | -31.31% | -22.52% | -23.23% | -21.21% |
| Treasury Stock & Other | 27.85% | 182.18% | 168.93% | 68.60% | 370.95% |
| Total Common Equity | 79.51% | 69.97% | 92.43% | 3.75% | -26.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 79.51% | 69.97% | 92.43% | 3.75% | -26.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 79.51% | 69.97% | 92.43% | 3.75% | -26.63% |
|
|
|||||